Unlike Emergency Departments that operate within public hospitals and some private hospitals, a Walk-in Specialist Emergency Clinic is located in the community and designed to provide comprehensive, coordinated acute care – from initial consultation and diagnostic services, to treatment and specialist referral if required – without the patient having to visit a hospital.
The first WiSE Clinic opened in Macquarie Park (North Ryde), New South Wales in early 2017, delivering immediate medical care when accidents or emergencies require more than a GP visit and are considered non-life threatening or unlikely to require admission to hospital.
Australian health journal spoke to the visionary, founder and CEO behind this WiSE Specialist Emergency clinic, Dr Pankaj Arora.
Dr Arora talks about the origins of his journey in emergency departments working in four continents as an Emergency Room physician for the past 28 years. His passion is to develop health care systems to help acute care in the community.
Stating 70% of people presenting at Emergency Departments in Australian Hospitals, not getting admitted, 7 years ago Dr Arora modelled these patients presenting to ER but breaking away from the hospital setting. This break away setting would deliver treatment by a team of doctors, allied health specialists, radiology, fracture clinic, chest pain clinic, TIA clinic, early pregnancy clinic and pathology services all co-located in the single facility.
Since putting the model in place and opening in 2017, the Macquarie Park WiSE Emergency Specialist Clinic has treated over 70,000 patients. Dr Arora sees it as a very efficient and cost effective model, where the patient is seen by a specialist in a multidisciplinary team within half an hour and receives results within an hour. He emphasises the clinic has not replaced General Practice nor the Emergency Department in hospital.
From the success of the Macquarie Park, NSW clinic, last year Dr Arora set his plans in motion to open a 2nd WiSE emergency specialist care clinic, this time in Queensland. This happened only after 3 years of planning and modelling prior to the opening of the new centre in September 2022. However since opening in Robina, Gold Coast, the new WiSE clinic has been treating on average 20 patients per day – a faster rate than the first 6 months of the Macquarie Park, NSW clinic.
In closing Dr Arora talks about the differences between the WiSE model and urgent care clinics. Scaled down versions of emergency care departments in urgent care centres fail to address the treatment required for patients between General Practice and at hospital emergency departments.
His plans now include opening 10 clinics in the next 5 years, with an expectation that 20-50 clinics would be needed across Australia in the medium to long term.
-
Australian Teletrial Program reaches significant milestones in trials and participants
Launched in 2022, the Australian Teletrial Program is an initiative designed to improve access to clinical trials for people living in regional and remote areas of Australia. It uses telemedicine and digital technologies to enable patients to participate in clinical trials without needing to travel long distances to major metropolitan centres, which can often be a barrier to participation for those in rural and isolated locations.
Recently Australian Health Journal met with Kaye Hewson, Director, Australian Teletrials Program, who spoke about the program’s recent achievements.
-
ARCS Annual Conference 2019
Earlier this month, ARCS Australia held it’s Annual Conference at the International Convention Centre Sydney – ICC Sydney, with the theme of putting patients at the centre of healthcare. Uniquely, the conference included a number of patients who attended, presented or were referenced.
-
Improved access to technology needed for people with Type 2 Diabetes needing insulin
The National Diabetes Services Scheme (NDSS) provides subsidised products for diabetes management; however, disparities exist in access to technology between those with Type 1 and Type 2 diabetes. While continuous glucose monitoring (CGM) devices are subsidised for Type 1, they are not available for Type 2 diabetes. ADEA advocates for equitable access to these essential tools, emphasising that all individuals with diabetes deserve the resources necessary for optimal management and reduced risk of complications. Without such technologies, many are forced to rely on finger pricking, which can be inconvenient and unsafe in settings such as the workplace and in higher education.
